TCA
LLY icon

Teewinot Capital Advisers’s Eli Lilly LLY Stock Holding History

Teewinot Capital Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50
Closed -$22.5K – 43
2024
Q4 		$22.5K Buy
+50
New +$41.4K ﹤0.01% 28

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Teewinot Capital Advisers's LLY Position: Q1 2026 in Review

Teewinot Capital Advisers reduced its Eli Lilly (LLY) stake by 19% in Q1 2026, selling an estimated $27.9M and leaving 114,611 shares worth $105M. The position accounts for 8.41% of the portfolio, ranked #2.

Teewinot Capital Advisers first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $153M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Teewinot Capital Advisers held 114,611 shares of Eli Lilly worth $105M as of Q1 2026.
  • Teewinot Capital Advisers sold 27,500 Eli Lilly shares in Q1 2026, an estimated $27.9M.
  • Eli Lilly made up 8.41% of Teewinot Capital Advisers's portfolio in Q1 2026, its #2 holding.
  • Teewinot Capital Advisers first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Teewinot Capital Advisers's Eli Lilly position peaked at $153M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Teewinot Capital Advisers's 13F filing for Q1 2026, filed 15 May 2026.